336 - Potential Impact of Targeted Sequencing on Central Line-associated Bloodstream Infection (CLABSI) at Stanford Health Care, 2015–2024

Rapid Fire Presenter(s)

• 

  Guillermo Rodriguez-Nava, MD

  Infectious Diseases Fellow
  Stanford University School of Medicine
  Stanford, CA, United States

Co-Author(s)

• GE

  Goar Egoryan, MD

  Clinical Assistant Professor
  Stanford University
  Menlo Park, California, United States
• KF

  Kyle Fu, MHA

  Stanford Health Care
  Stanford, California, United States
• JS

  John Shepard, BA, MBA, MHA

  Stanford University
  Palo Alto, California, United States
• KM

  Karen McIntyre, RN, MSN

  Director, Infection Prevention & Control and Antimicrobial Stewardship
  Stanford Healthcare
  Stanford, California, United States
• MS

  Mindy M. Sampson, DO

  Stanford University
  Stanford, California, United States
• 

  Jorge Salinas, MD

  Hospital Epidemiologist
  Stanford University
  Palo Alto, CA, United States